FDA Approves First Therapy for Allergic Fungal Rhinosinusitis - Top_Thought_Leaders - MDSpire

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 2 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

  • by Kathryn Wighton

  • February 25, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Electroencephalographic abnormalities and clinical phenotypes in children with autism spectrum disorder: a single center cohort study

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies